News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
189,156 Results
Type
Article (16818)
Company Profile (35)
Press Release (172611)
Multimedia
Podcasts (8)
Webinars (3)
Section
Business (55860)
Career Advice (240)
Deals (6967)
Drug Delivery (30)
Drug Development (21388)
Employer Resources (27)
FDA (3404)
Job Trends (3969)
News (81146)
Policy (6541)
Tag
2027 BioCapital Standard (2)
2027 Bio NC Standard (1)
2027 Biotech Bay Elite (2)
2027 Genetown Standard (2)
Academia (1863)
Accelerated approval (16)
ADA (9)
Adcomms (12)
Allergies (37)
Alliances (16508)
ALS (96)
Alzheimer's disease (695)
Antibody-drug conjugate (ADC) (148)
Approvals (3603)
Artificial intelligence (310)
ASCO (128)
Autoimmune disease (81)
Automation (24)
Bankruptcy (40)
Belgium (1)
Best Places to Work (3367)
BIO (19)
Biologics (4)
BIOSECURE Act (15)
Biosimilars (26)
BioSpace Insights (31)
Biotechnology (33)
Bispecific (1)
Bladder cancer (82)
Brain cancer (39)
Breast cancer (375)
Cancer (2693)
Cardiovascular disease (115)
Career advice (234)
Career pathing (7)
CAR-T (144)
CDC (17)
CDMO (35)
Celiac Disease (1)
Cell therapy (344)
Cervical cancer (21)
Clinical research (17921)
Collaboration (823)
Commercialization (2)
Company closure (1)
Compensation (67)
Complete response letters (9)
COVID-19 (1169)
CRISPR (77)
C-suite (396)
Cystic fibrosis (42)
Data (2769)
Decentralized trials (1)
Denatured (2)
Depression (43)
Dermatology (22)
Diabetes (130)
Diagnostics (2971)
Digital health (16)
Diversity (3)
Diversity, equity & inclusion (10)
Drug discovery (135)
Drug pricing (30)
Drug shortages (2)
Duchenne muscular dystrophy (58)
Earnings (13709)
Editorial (15)
Employer branding (3)
Employer resources (25)
Events (25996)
Executive appointments (322)
Eye disease (1)
FDA (4442)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (14)
Frontotemporal dementia (18)
Funding (813)
Gene editing (160)
Generative AI (14)
Gene therapy (306)
GLP-1 (169)
Government (1402)
Grass and pollen (1)
Guidances (102)
Healthcare (5774)
Hematology (63)
HIV (26)
Huntington's disease (14)
IgA nephropathy (14)
Immunology and inflammation (41)
Immuno-oncology (39)
Indications (55)
Infectious disease (1279)
Inflammatory bowel disease (71)
Inflation Reduction Act (2)
Influenza (32)
Intellectual property (71)
Interviews (24)
IPO (3463)
IRA (13)
Job creations (685)
Job search strategy (217)
JPM (4)
Kidney cancer (11)
Labor market (29)
Layoffs (81)
Leadership (2)
Legal (1141)
Licensing (8)
Liver cancer (37)
Longevity (19)
Lung cancer (355)
Lymphoma (207)
Machine learning (27)
Management (8)
Manufacturing (251)
Marketing (5)
MASH (49)
Medical device (2803)
Medtech (2836)
Mergers & acquisitions (3897)
Metabolic disorders (254)
mRNA (70)
Multiple sclerosis (56)
NASH (5)
Netherlands (1)
Neurodegenerative disease (161)
Neuropsychiatric disorders (16)
Neuroscience (1241)
NextGen: Class of 2026 (1846)
Non-profit (2010)
Now hiring (13)
Obesity (69)
Opinion (94)
Ovarian cancer (85)
Pain (82)
Pancreatic cancer (162)
Parkinson's disease (137)
Partnered (12)
Patents (129)
Patient recruitment (243)
Patient selection (2)
Peanut (12)
People (18773)
Peptides (2)
Pharmaceutical (7)
Pharmacy benefit managers (2)
Phase 1 (6289)
Phase 2 (8239)
Phase 3 (5361)
Pipeline (2967)
Policy (97)
Postmarket research (577)
Preclinical (2868)
Press Release (30)
Prostate cancer (127)
Psychedelics (18)
Radiopharmaceuticals (70)
Rare diseases (330)
Real estate (1554)
Recruiting (13)
Regenerative medicine (1)
Regulatory (5472)
Reports (14)
Research institute (2068)
Resumes & cover letters (18)
Rett syndrome (12)
RNA editing (4)
RSV (14)
Schizophrenia (53)
Series A (111)
Series B (66)
Sickle cell disease (50)
Special edition (1)
Spinal muscular atrophy (29)
Sponsored (7)
Startups (1320)
Stomach cancer (3)
Supply chain (28)
Tariffs (14)
The Weekly (6)
Vaccines (360)
Venture capital (44)
Weight loss (31)
Wet AMD (1)
Women's health (29)
Worklife (4)
Date
Last 7 days (143)
Last 30 days (506)
Last 365 days (7346)
2026 (5283)
2025 (7477)
2024 (9236)
2023 (11028)
2022 (14548)
2021 (16203)
2020 (15061)
2019 (12995)
2018 (9638)
2017 (9138)
2016 (9126)
2015 (10418)
2014 (7642)
2013 (6358)
2012 (6600)
2011 (6853)
2010 (5834)
Location
Africa (231)
Alabama (74)
Alaska (3)
Arizona (112)
Arkansas (4)
Asia (15000)
Australia (2390)
California (3722)
Canada (814)
China (617)
Colorado (172)
Connecticut (171)
Delaware (142)
Europe (24341)
Florida (628)
Georgia (89)
Hawaii (2)
Idaho (13)
Illinois (297)
India (23)
Indiana (116)
Iowa (20)
Japan (200)
Kansas (33)
Kentucky (25)
Louisiana (13)
Maine (14)
Maryland (498)
Massachusetts (2437)
Michigan (59)
Minnesota (166)
Mississippi (2)
Missouri (62)
Montana (7)
Nebraska (9)
Nevada (28)
New Hampshire (19)
New Jersey (1123)
New Mexico (16)
New York (1115)
North Carolina (511)
North Dakota (10)
Northern California (1896)
Ohio (115)
Oklahoma (9)
Oregon (11)
Pennsylvania (595)
Puerto Rico (3)
Rhode Island (20)
South America (294)
South Carolina (23)
Southern California (1417)
Tennessee (79)
Texas (855)
United States (13530)
Utah (125)
Vermont (1)
Virginia (88)
Washington D.C. (36)
Washington State (333)
West Virginia (2)
Wisconsin (55)
189,156 Results for "beijing genomics institute bgi".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
MUSE Cells Now Available at Longevity Medical Institute®
As part of its Regenerative Neurology Program, Longevity Medical Institute® is making MUSE cell therapy available to select patients, using cells produced in-house at the Institute’s biotechnology laboratory.
September 18, 2026
·
1 min read
Press Releases
Telo Genomics Provides Positive Interim Data from Ongoing Clinical Trial Advancing Genomic Instability-Based Relapse Risk Assessment
Clinical Study on Track to Meet Primary Endpoints with Interim Data Demonstrating Blood-Based Assay Capable of Predicting Relapse Risk Through Analysis of Genomic Instability and Telomere Architecture
July 16, 2026
·
8 min read
Press Releases
Inocras and Broad Institute Researchers Present New TCGA Whole-Genome Cancer Insights, Accelerating Discovery in Cancer Genomics
April 20, 2026
·
5 min read
Press Releases
Nabsys Announces Advancements in Detection of Repeat Contraction and Expansion Disorders Via Electronic Genome Mapping in Collaboration with Leading European Institutions
June 15, 2026
·
5 min read
Press Releases
Ultima Genomics to Advance Pangenome-Aware Whole Genome Sequencing Analysis at Population Scale in Collaboration with NVIDIA, using Google’s DeepVariant
September 9, 2026
·
3 min read
Press Releases
Dr. Tobias Janowitz joins Feinstein Institutes as new Institute of Cancer Research director
August 31, 2026
·
3 min read
Press Releases
Telo Genomics Grants Stock Options
August 4, 2026
·
1 min read
Press Releases
Ecotone AI Breaks the Genomics Cost Barrier, Cutting Genome Processing from $100 to Under $1
New GPU-powered system reduces whole-genome processing time from hours to minutes, unlocking population-scale genetic discovery and accelerating rare disease drug development
February 25, 2026
·
1 min read
Press Releases
Xpress Genomics Joins Parse Biosciences’ Certified Service Provider Network
July 29, 2026
·
1 min read
Press Releases
GenomOncology Announces Integrated End-to-End Workflow Using PacBio’s Long-Read Whole-Genome Sequencing Technology in Oncology
July 30, 2026
·
3 min read
1 of 18,916
Next
